Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

Area of Science:

• Oncology
• Genetics
• Epigenetics

Background:

• Traditionally, genetic mutations were considered the main drivers of cancer progression.
• Epigenetic modifications, which alter DNA expression without changing the DNA sequence, also play a significant role in heritable traits and cancer.
• Advances in understanding cancer genetics have enabled more precise therapeutic strategies.

Purpose of the Study:

• To review the current understanding of genetic factors in cancer development.
• To discuss targeted therapies designed to combat cancer cells.
• To explore the relationship between cancer genetics and targeted treatment approaches.

Main Methods:

• Literature review of genetic and epigenetic factors in cancer.
• Analysis of targeted therapy mechanisms and their specificity.
• Examination of the interplay between genetic alterations and therapeutic responses.

Main Results:

• Genetic mutations are key drivers of tumor progression.
• Epigenetic changes influence gene expression and heritable traits.
• Targeted therapies provide a more specific approach to cancer treatment compared to traditional chemotherapy, minimizing side effects.

Conclusions:

• Understanding the genetic and epigenetic landscape of cancer is crucial for developing effective treatments.
• Targeted therapies represent a significant advancement in personalized cancer care.
• The integration of genetic insights and targeted therapeutic strategies is essential for improving patient outcomes.